Solesence (NASDAQ:SLSN – Get Free Report) and Lifevantage (NASDAQ:LFVN – Get Free Report) are both small-cap consumer staples companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, risk, earnings and profitability.
Analyst Ratings
This is a summary of current ratings and recommmendations for Solesence and Lifevantage, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Solesence | 1 | 0 | 0 | 0 | 1.00 |
| Lifevantage | 0 | 3 | 1 | 0 | 2.25 |
Lifevantage has a consensus target price of $6.75, indicating a potential upside of 36.50%. Given Lifevantage’s stronger consensus rating and higher possible upside, analysts clearly believe Lifevantage is more favorable than Solesence.
Institutional & Insider Ownership
70.2% of Solesence shares are owned by institutional investors. Comparatively, 35.3% of Lifevantage shares are owned by institutional investors. 4.8% of Solesence shares are owned by insiders. Comparatively, 13.6% of Lifevantage shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Profitability
This table compares Solesence and Lifevantage’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Solesence | 4.77% | 18.04% | 6.17% |
| Lifevantage | 1.58% | 16.35% | 8.90% |
Valuation and Earnings
This table compares Solesence and Lifevantage”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Solesence | $62.06 million | 1.90 | $1.79 million | $0.04 | 41.77 |
| Lifevantage | $182.59 million | 0.34 | $5.07 million | $0.21 | 23.55 |
Lifevantage has higher revenue and earnings than Solesence. Lifevantage is trading at a lower price-to-earnings ratio than Solesence, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
Solesence has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500. Comparatively, Lifevantage has a beta of 0.71, meaning that its share price is 29% less volatile than the S&P 500.
Summary
Lifevantage beats Solesence on 8 of the 14 factors compared between the two stocks.
About Solesence
Solesence is a beauty and skincare product development and manufacturing company. It works with brands to formulate and produce products, with capabilities spanning product development, regulatory support and manufacturing. The company’s offerings include sunscreens, skincare products and color cosmetics, including mineral-based sun-protection formulations. Its work supports brands seeking product development and production services rather than focusing solely on sales under a single consumer brand.
About Lifevantage
LifeVantage Corporation is a health and wellness company that develops and sells dietary supplements, skincare products and other wellness offerings. Its product range includes Protandim supplements and the TrueScience skincare line, with products marketed around the company’s focus on nutrigenomics—the study of how nutrition interacts with gene expression. Founded in 2003, LifeVantage primarily sells through independent consultants and online channels. The company serves customers in markets across North America, Europe and the Asia-Pacific region.
Receive News & Ratings for Solesence Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solesence and related companies with MarketBeat.com's FREE daily email newsletter.
